Corrigendum to: “Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death” [Biomed. Pharmacother. 153 (2022) 113511]
Li Liu,
XueFeng An,
Michael Schaefer,
Bin Yan,
Carolina de la Torre,
Stefan Hillmer,
Jury Gladkich,
Ingrid Herr
Affiliations
Li Liu
Section Surgical Research, Molecular OncoSurgery, Department of General, Visceral and Transplantation Surgery, Ruprecht Karls University of Heidelberg, Medical Faculty Heidelberg, Germany
XueFeng An
Section Surgical Research, Molecular OncoSurgery, Department of General, Visceral and Transplantation Surgery, Ruprecht Karls University of Heidelberg, Medical Faculty Heidelberg, Germany
Michael Schaefer
Section Surgical Research, Molecular OncoSurgery, Department of General, Visceral and Transplantation Surgery, Ruprecht Karls University of Heidelberg, Medical Faculty Heidelberg, Germany
Bin Yan
Section Surgical Research, Molecular OncoSurgery, Department of General, Visceral and Transplantation Surgery, Ruprecht Karls University of Heidelberg, Medical Faculty Heidelberg, Germany
Carolina de la Torre
Microarray Analytics - NPGS Core Facility, Medical Faculty Mannheim, Ruprecht Karls University of Heidelberg, Heidelberg, Germany
Stefan Hillmer
Electron Microscopy Core Facility, University of Heidelberg, Heidelberg, Germany
Jury Gladkich
Section Surgical Research, Molecular OncoSurgery, Department of General, Visceral and Transplantation Surgery, Ruprecht Karls University of Heidelberg, Medical Faculty Heidelberg, Germany
Ingrid Herr
Section Surgical Research, Molecular OncoSurgery, Department of General, Visceral and Transplantation Surgery, Ruprecht Karls University of Heidelberg, Medical Faculty Heidelberg, Germany; Correspondence to: Section Surgical Research, University of Heidelberg, Im Neuenheimer Feld 365, 69120 Heidelberg, Germany.
